Business Wire

PA-PMI

17.9.2018 17:05:04 CEST | Business Wire | Press release

Share
PMI 2018 Pulse of the Profession® In-Depth Report

Project Management Institute (PMI) today unveiled its Pulse of the Profession® in-depth report: The Project Manager of the Future: Developing Digital-Age Project Management Skills to Thrive in Disruptive Times . Based on insights from innovator organizations, the latest research outlines skills that are critical for employees who manage projects and programs, and behaviors employers will be required to demonstrate in order to face today’s business challenges brought forth by disruptive technologies. The report highlights what will be the most in-demand skills and competencies for workers, discusses the future of collaboration and touches on the potential professional culture shifts that may be required given the changing work environment.

Key takeaways from the report include:

  • KEY COMPETENCIES ALIGN WITH DIGITAL TRANSFORMATION: The most important digital-era skills for prospective project leaders will be data science (data management, analytics, and big data), an innovative mindset, security and privacy knowledge, legal and regulatory compliance knowledge, the ability to make data-driven decisions, and collaborative leadership.

    Organizations can ensure their workforce has mastery of these skills by factoring them into the recruitment process, as well as investing in training and professional development. In fact, the report indicates the vast majority of innovator companies (80 percent) are highly effective at recruiting and hiring project managers with the skill sets necessary to drive the organization forward into a digital environment. And, nearly three-quarters of innovator companies consider their organizations highly effective at training project leaders.
  • THERE IS NO ONE SIZE FITS ALL APPROACH : Project leaders use multiple approaches, including collaborative platforms and work management tools, along with emerging, hybrid, and traditional methods, to help them deliver successful outcomes. This aligns with the concept of adopting a value delivery landscape mindset, one that allows organizations to minimize risks, control costs, and increase value by selecting the approach that best fits the needs of the project and the organization.
  • VIEW DISRUPTION AS AN OPPORTUNITY : Innovators are creating a culture that views disruption as an opportunity to enable dexterity. Rather than view disruption as a threat, innovator companies value the technological shift toward a digital environment and continue to pave the way for evolving and leveraging advances like human-machine interaction, where people and machines work together.

Actions for Employers

To effectively manage the change, the report outlines several internal process improvements for organizations to focus on:

  • MAKE TRAINING AND DEVELOPMENT A PRIORITY: As project leaders take on a more expansive role, training and skills development are even more essential. Innovator companies are responding with formal processes for developing those competencies through internal and external training.
  • EMBRACE THE NEXT-LEVEL TOOLS AND APPROACHES THAT WORK: Digital transformation relies on an organization’s ability to leverage evolving technology and tools. Organizations must support what their project leaders see as the right approach or process – be it disciplined agile delivery or design thinking. PMI expects the use of new practices to grow to the usage levels of the leading current practices, including lean agile, Scrum, waterfall, and Kanban.
  • NURTURE A FLEXIBLE CULTURE: Create and nurture a culture that views disruptive technologies as an opportunity to evolve best practices. The report found the vast majority (80 percent) of innovator organizations value the technological shift toward a digital environment and encourage their project leaders to take advantage of flexible practices that allow them to move beyond the routine tasks, such as scheduling, to higher-level work, such as strategic thinking and planning.

“Project leaders are becoming even more essential as organizations continue to recognize that strategy is implemented through projects and programs,” said Mark A. Langley, President and CEO of Project Management Institute. “Today more than ever before, organizations need project leaders with an ability to learn and keep pace with technology. As disruptive technology frees them from routine tasks such as scheduling and gathering requirements, the role of the project leader is expanding to be one of an innovator, a strategic advisor, communicator, big thinker, and versatile manager.”

PMI’s Pulse of the Profession® in-depth commissioned research was conducted online by Forrester Consulting for PMI among 469 HR professionals who hire, direct, oversee, and/or train staff that work on projects or programs, as well as 523 project leaders. The HR professionals are managers or higher level at mid-to-large size organizations. Respondents were in the United States, Canada, Brazil, the United Kingdom, France, Germany, China, India, and Australia. Forrester Consulting also conducted in-depth interviews on behalf of PMI with six HR professionals and 10 project leaders.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Founded in 1969, PMI delivers value for more than three million professionals working in nearly every country in the world through global advocacy, collaboration, education and research. We advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives.

Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute.

Contact:

Project Management Institute (PMI) Mary Ortega +1 610-356-4600 x7030 mary.ortega@pmi.org

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye